Lars Hvilsted Rasmussen
Overview
Explore the profile of Lars Hvilsted Rasmussen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albertsen I, Nielsen P, Sogaard M, Goldhaber S, Overvad T, Rasmussen L, et al.
Am J Med
. 2018 Sep;
131(9):1067-1074.e4.
PMID: 30266273
Purpose: In this study, we aimed to estimate recurrence risk after incident venous thromboembolism, stratified according to unprovoked, provoked, and cancer-related venous thromboembolism in a prospective cohort of inpatients and...
2.
Fumagalli S, Said S, Laroche C, Gabbai D, Marchionni N, Boriani G, et al.
JACC Clin Electrophysiol
. 2018 May;
1(4):326-334.
PMID: 29759321
Objectives: This study sought to compare age-related differences in presentation, treatment, and outcome of atrial fibrillation (AF) in a wide cohort of European subjects. Background: AF is the most common...
3.
Ullum H, Hersom C, Wewer U, Skott O, Nielsen L, Rasmussen L
Ugeskr Laeger
. 2018 Mar;
180(12).
PMID: 29559072
No abstract available.
4.
Boriani G, Laroche C, Diemberger I, Popescu M, Rasmussen L, Petrescu L, et al.
Sci Rep
. 2017 Feb;
7:42379.
PMID: 28225014
No abstract available.
5.
Boriani G, Laroche C, Diemberger I, Popescu M, Rasmussen L, Petrescu L, et al.
Sci Rep
. 2016 Jul;
6:30271.
PMID: 27466080
We assessed 1-year outcomes in patients with atrial fibrillation enrolled in the EurObservational Research Programme AF General Pilot Registry (EORP-AF), in relation to kidney function, as assessed by glomerular filtration...
6.
Melgaard L, Gorst-Rasmussen A, Rasmussen L, Lip G, Larsen T
PLoS One
. 2016 Mar;
11(3):e0152269.
PMID: 27015524
Background: Stroke and mortality risk among heart failure patients previously diagnosed with different manifestations of vascular disease is poorly described. We conducted an observational study to evaluate the stroke and...
7.
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al.
Thromb Haemost
. 2016 Mar;
115(4):685-711.
PMID: 26952877
Until recently, vitamin K antagonists (VKAs) were the only available oral anticoagulants evaluated for long-term treatment of patients with coronary heart disease (CHD), particularly after an acute coronary syndrome (ACS)....
8.
Melgaard L, Gorst-Rasmussen A, Sogaard P, Rasmussen L, Lip G, Larsen T
Int J Cardiol
. 2016 Feb;
209:1-6.
PMID: 26874450
Objective: The risk of ischemic stroke, systemic thromboembolism, and all-cause death among heart failure patients previously diagnosed with diabetes mellitus is poorly described. We evaluated the risk of these endpoints...
9.
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu M, Rasmussen L, et al.
Europace
. 2016 Jan;
18(5):648-57.
PMID: 26826133
Aims: Atrial fibrillation (AF) has different presentations (first detected, paroxysmal, persistent, permanent), with uncertain impact on outcome. The aim of this study was to investigate clinical presentation, management, and outcome...
10.
Lip G, Laroche C, Popescu M, Rasmussen L, Vitali-Serdoz L, Dan G, et al.
Europace
. 2015 Sep;
17(12):1777-86.
PMID: 26321406
Aims: Guideline-adherent therapy for stroke prevention in atrial fibrillation has been associated with better outcomes, in terms of thromboembolism (TE) and bleeding. Methods And Results: In this report from the...